Historical record - last NADAC effective date: 1/1/2018
Product Information
MENEST 0.625 MG TABLET is a brand (anda) product labeled by Pfizer Inc., priced at $2.4046 per EA under NDC 61570007301. Its NADAC has been published 269 times since Nov 28, 2013.
FDA first approved this application before 1982.
Strength
.625 mg/1
Manufacturer
Pfizer Inc.NDC
61570007301
Classification
Brand (ANDA)
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/1/2018
Active Ingredients
ESTROGENS, ESTERIFIEDApproval Type
Generic (ANDA)
FDA Application
ANDA084948FDA Approved
Before 1982
On Market Since
9/28/1977
Price Statistics
The NADAC for MENEST 0.625 MG TABLET has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 100.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4046 per EA |
|---|---|
| All-time high | $2.4046 (Jan 16, 2019) |
| All-time low | $1.1997 (Nov 28, 2013) |
| Median price | $1.8523 |
| Average price | $1.8395 |
| Largest weekly change | +20.0% (Jan 6, 2016) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+100.4%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the esterified estrogens market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
esterified estrogens market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MENEST 0.625 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MENEST 0.625 MG TABLET, manufactured by Pfizer Inc., is $2.4046 per EA (NDC 61570007301), effective Jan 16, 2019.
How has the price of MENEST 0.625 MG TABLET changed over time?
Over the history we have for it, the NADAC for MENEST 0.625 MG TABLET has risen 100.4%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MENEST 0.625 MG TABLET?
Since Nov 28, 2013, the NADAC for MENEST 0.625 MG TABLET has ranged from a low of $1.1997 (Nov 28, 2013) to a high of $2.4046 (Jan 16, 2019), with a median of $1.8523 per EA.
Are there cheaper alternatives to MENEST 0.625 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MENEST 0.625 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MENEST 0.625 MG TABLET?
MENEST 0.625 MG TABLET (NDC 61570007301) is labeled by Pfizer Inc., and CMS classifies it as a brand (anda) product.